Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
"Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data." Int J Mol Sci
Portfolio company RAPT Therapeutics and development partner Shanghai Jeyou Pharmaceutical Co., Ltd announced positive topline data from Jeyou's Phase 2 trial of RPT904 (JYB1904) as monotherapy in chronic spontaneous urticaria (CSU)
Asanuma, M., Miyazaki, I
This superior formula continues to keep clients flawless, matte, and approachable
GHK-Cu is not a medical treatment, and products containing it are not intended to diagnose, treat, cure, or prevent any disease
US$ 25.53
US$ 24.80
US$ 22.91
US$ 24.10
US$ 21.61
US$ 27.19
US$ 27.74
US$ 29.10
US$ 26.32
US$ 28.08
US$ 27.89
US$ 25.71
US$ 26.24
US$ 21.59
